CN109749986A - 一种由人多能干细胞分化获得胰腺前体细胞及胰岛β细胞的方法 - Google Patents
一种由人多能干细胞分化获得胰腺前体细胞及胰岛β细胞的方法 Download PDFInfo
- Publication number
- CN109749986A CN109749986A CN201910190210.4A CN201910190210A CN109749986A CN 109749986 A CN109749986 A CN 109749986A CN 201910190210 A CN201910190210 A CN 201910190210A CN 109749986 A CN109749986 A CN 109749986A
- Authority
- CN
- China
- Prior art keywords
- culture medium
- cell
- islet
- diabetes
- beta cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0676—Pancreatic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0613—Cells from endocrine organs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0676—Pancreatic cells
- C12N5/0678—Stem cells; Progenitor cells; Precursor cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/02—Atmosphere, e.g. low oxygen conditions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/117—Keratinocyte growth factors (KGF-1, i.e. FGF-7; KGF-2, i.e. FGF-12)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/415—Wnt; Frizzeled
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (6)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910190210.4A CN109749986B (zh) | 2019-03-13 | 2019-03-13 | 一种由人多能干细胞分化获得胰腺前体细胞及胰岛β细胞的方法 |
PCT/CN2020/078997 WO2020182190A1 (zh) | 2019-03-13 | 2020-03-12 | 一种由人多能干细胞分化获得胰腺前体细胞及胰岛β细胞的方法 |
US17/438,241 US20220186188A1 (en) | 2019-03-13 | 2020-03-12 | Method for Obtaining Pancreatic Progenitor Cells and Pancreatic Islet Beta Cells By Means of Differentiation of Human Pluripotent Stem Cells |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910190210.4A CN109749986B (zh) | 2019-03-13 | 2019-03-13 | 一种由人多能干细胞分化获得胰腺前体细胞及胰岛β细胞的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109749986A true CN109749986A (zh) | 2019-05-14 |
CN109749986B CN109749986B (zh) | 2021-04-02 |
Family
ID=66408674
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910190210.4A Active CN109749986B (zh) | 2019-03-13 | 2019-03-13 | 一种由人多能干细胞分化获得胰腺前体细胞及胰岛β细胞的方法 |
Country Status (3)
Country | Link |
---|---|
US (1) | US20220186188A1 (zh) |
CN (1) | CN109749986B (zh) |
WO (1) | WO2020182190A1 (zh) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111269878A (zh) * | 2020-01-19 | 2020-06-12 | 武汉大学 | 一种人多能干细胞转化为扩展多能干细胞的专用培养基及其应用 |
WO2020182190A1 (zh) * | 2019-03-13 | 2020-09-17 | 深圳华源再生医学有限公司 | 一种由人多能干细胞分化获得胰腺前体细胞及胰岛β细胞的方法 |
CN112251396A (zh) * | 2020-10-09 | 2021-01-22 | 北京呈诺医学科技有限公司 | 培养基及其应用与诱导性多能干细胞向胰岛分化的方法 |
CN112522181A (zh) * | 2020-12-29 | 2021-03-19 | 苏州方舟生物科技有限公司 | 体外诱导产生人胰岛β细胞的培养基体系及方法 |
CN112961823A (zh) * | 2021-03-19 | 2021-06-15 | 上海爱萨尔生物科技有限公司 | 一种诱导多能干细胞定向分化制备胰岛β细胞的培养液 |
CN112980771A (zh) * | 2021-03-05 | 2021-06-18 | 盛泰英诺(嘉兴)医疗科技有限公司 | 一种制备胰腺beta细胞的方法及其应用 |
CN112980774A (zh) * | 2021-03-19 | 2021-06-18 | 上海爱萨尔生物科技有限公司 | 一种诱导多能干细胞定向分化制备胰岛β细胞的培养方法 |
CN113046299A (zh) * | 2021-03-19 | 2021-06-29 | 上海爱萨尔生物科技有限公司 | 一种诱导多能干细胞定向分化制备胰岛β细胞的添加剂 |
CN113234664A (zh) * | 2021-05-11 | 2021-08-10 | 澳门大学 | 一种胰腺祖细胞的制备方法及其应用 |
CN113502258A (zh) * | 2021-07-09 | 2021-10-15 | 多能干细胞再生医学科技(广州)有限公司 | 一种由人多能干细胞分化获得胰腺前体细胞及胰岛β细胞的方法 |
CN113599522A (zh) * | 2021-08-03 | 2021-11-05 | 武汉大学 | Kdm6作为靶标在制备用于提高早期神经外胚层分化效率的药物中的应用 |
CN114703123A (zh) * | 2022-05-20 | 2022-07-05 | 呈诺再生医学科技(北京)有限公司 | 一种通过调节NGN3表达促进iPSC向胰岛细胞分化的方法 |
CN114807013A (zh) * | 2022-04-25 | 2022-07-29 | 宫念樵 | 一种外周血干细胞分化成内胚层细胞的方法及其应用 |
CN114807015A (zh) * | 2022-05-20 | 2022-07-29 | 呈诺再生医学科技(北京)有限公司 | 一种促进胰岛α细胞转化为β细胞的诱导方法及其应用 |
CN113234664B (zh) * | 2021-05-11 | 2024-05-10 | 澳门大学 | 一种胰腺祖细胞的制备方法及其应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101541953A (zh) * | 2006-06-02 | 2009-09-23 | 佐治亚大学研究基金会 | 通过从人胚胎干细胞获得的定形内胚层细胞的分化得到胰和肝内胚层细胞及组织 |
CN106795487A (zh) * | 2014-08-04 | 2017-05-31 | 武田药品工业株式会社 | 胰腺祖细胞的增殖方法 |
WO2017188378A1 (ja) * | 2016-04-28 | 2017-11-02 | 武田薬品工業株式会社 | 多能性幹細胞由来膵前駆細胞の純化法とその増幅法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105176919A (zh) * | 2007-07-18 | 2015-12-23 | 生命扫描有限公司 | 人胚胎干细胞的分化 |
AU2012355698B2 (en) * | 2011-12-22 | 2018-11-29 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells into single hormonal insulin positive cells |
SG10201802167TA (en) * | 2013-09-20 | 2018-04-27 | Repairon Gmbh | A method to direct differentiation of pluripotent stem cells into functional heart muscle |
CN108359636B (zh) * | 2018-02-07 | 2021-04-30 | 苏州大学 | 一种提高多能干细胞定向分化为心肌细胞的诱导方法 |
CN109749986B (zh) * | 2019-03-13 | 2021-04-02 | 武汉大学 | 一种由人多能干细胞分化获得胰腺前体细胞及胰岛β细胞的方法 |
-
2019
- 2019-03-13 CN CN201910190210.4A patent/CN109749986B/zh active Active
-
2020
- 2020-03-12 US US17/438,241 patent/US20220186188A1/en active Pending
- 2020-03-12 WO PCT/CN2020/078997 patent/WO2020182190A1/zh active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101541953A (zh) * | 2006-06-02 | 2009-09-23 | 佐治亚大学研究基金会 | 通过从人胚胎干细胞获得的定形内胚层细胞的分化得到胰和肝内胚层细胞及组织 |
CN106795487A (zh) * | 2014-08-04 | 2017-05-31 | 武田药品工业株式会社 | 胰腺祖细胞的增殖方法 |
WO2017188378A1 (ja) * | 2016-04-28 | 2017-11-02 | 武田薬品工業株式会社 | 多能性幹細胞由来膵前駆細胞の純化法とその増幅法 |
Cited By (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020182190A1 (zh) * | 2019-03-13 | 2020-09-17 | 深圳华源再生医学有限公司 | 一种由人多能干细胞分化获得胰腺前体细胞及胰岛β细胞的方法 |
CN111269878B (zh) * | 2020-01-19 | 2022-02-11 | 深圳市北科生物科技有限公司 | 一种人多能干细胞转化为扩展多能干细胞的专用培养基及其应用 |
CN111269878A (zh) * | 2020-01-19 | 2020-06-12 | 武汉大学 | 一种人多能干细胞转化为扩展多能干细胞的专用培养基及其应用 |
CN112251396A (zh) * | 2020-10-09 | 2021-01-22 | 北京呈诺医学科技有限公司 | 培养基及其应用与诱导性多能干细胞向胰岛分化的方法 |
CN112251396B (zh) * | 2020-10-09 | 2022-08-16 | 北京呈诺医学科技有限公司 | 培养基及其应用与诱导性多能干细胞向胰岛分化的方法 |
CN112522181A (zh) * | 2020-12-29 | 2021-03-19 | 苏州方舟生物科技有限公司 | 体外诱导产生人胰岛β细胞的培养基体系及方法 |
CN112522181B (zh) * | 2020-12-29 | 2023-02-17 | 苏州方舟生物科技有限公司 | 体外诱导产生人胰岛β细胞的培养基体系及方法 |
CN112980771B (zh) * | 2021-03-05 | 2023-12-19 | 贝康医学科技有限公司 | 一种制备胰腺beta细胞的方法及其应用 |
CN112980771A (zh) * | 2021-03-05 | 2021-06-18 | 盛泰英诺(嘉兴)医疗科技有限公司 | 一种制备胰腺beta细胞的方法及其应用 |
WO2022183740A1 (zh) * | 2021-03-05 | 2022-09-09 | 贝康医学科技有限公司 | 一种制备胰腺beta细胞的方法及其应用 |
CN112980774A (zh) * | 2021-03-19 | 2021-06-18 | 上海爱萨尔生物科技有限公司 | 一种诱导多能干细胞定向分化制备胰岛β细胞的培养方法 |
CN112961823A (zh) * | 2021-03-19 | 2021-06-15 | 上海爱萨尔生物科技有限公司 | 一种诱导多能干细胞定向分化制备胰岛β细胞的培养液 |
CN112980774B (zh) * | 2021-03-19 | 2022-04-01 | 上海爱萨尔生物科技有限公司 | 一种诱导多能干细胞定向分化制备胰岛β细胞的培养方法 |
CN112961823B (zh) * | 2021-03-19 | 2024-01-23 | 上海爱萨尔生物科技有限公司 | 一种诱导多能干细胞定向分化制备胰岛β细胞的培养液 |
CN113046299A (zh) * | 2021-03-19 | 2021-06-29 | 上海爱萨尔生物科技有限公司 | 一种诱导多能干细胞定向分化制备胰岛β细胞的添加剂 |
CN113234664B (zh) * | 2021-05-11 | 2024-05-10 | 澳门大学 | 一种胰腺祖细胞的制备方法及其应用 |
CN113234664A (zh) * | 2021-05-11 | 2021-08-10 | 澳门大学 | 一种胰腺祖细胞的制备方法及其应用 |
CN113502258B (zh) * | 2021-07-09 | 2022-06-21 | 多能干细胞再生医学科技(广州)有限公司 | 一种由人多能干细胞分化获得胰腺前体细胞及胰岛β细胞的方法 |
CN113502258A (zh) * | 2021-07-09 | 2021-10-15 | 多能干细胞再生医学科技(广州)有限公司 | 一种由人多能干细胞分化获得胰腺前体细胞及胰岛β细胞的方法 |
CN113599522A (zh) * | 2021-08-03 | 2021-11-05 | 武汉大学 | Kdm6作为靶标在制备用于提高早期神经外胚层分化效率的药物中的应用 |
CN113599522B (zh) * | 2021-08-03 | 2022-09-20 | 深圳市北科生物科技有限公司 | Kdm6作为靶标在制备用于提高早期神经外胚层分化效率的药物中的应用 |
CN114807013A (zh) * | 2022-04-25 | 2022-07-29 | 宫念樵 | 一种外周血干细胞分化成内胚层细胞的方法及其应用 |
CN114807013B (zh) * | 2022-04-25 | 2023-11-17 | 宫念樵 | 一种外周血干细胞分化成内胚层细胞的方法及其应用 |
CN114703123A (zh) * | 2022-05-20 | 2022-07-05 | 呈诺再生医学科技(北京)有限公司 | 一种通过调节NGN3表达促进iPSC向胰岛细胞分化的方法 |
CN114703123B (zh) * | 2022-05-20 | 2022-12-13 | 呈诺再生医学科技(北京)有限公司 | 一种通过调节NGN3表达促进iPSC向胰岛细胞分化的方法 |
CN114807015A (zh) * | 2022-05-20 | 2022-07-29 | 呈诺再生医学科技(北京)有限公司 | 一种促进胰岛α细胞转化为β细胞的诱导方法及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN109749986B (zh) | 2021-04-02 |
WO2020182190A1 (zh) | 2020-09-17 |
US20220186188A1 (en) | 2022-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109749986A (zh) | 一种由人多能干细胞分化获得胰腺前体细胞及胰岛β细胞的方法 | |
Nagata et al. | Evaluation of insulin secretion of isolated rat islets cultured in extracellular matrix | |
Dubois et al. | Isolation of human adipose-derived stem cells from biopsies and liposuction specimens | |
CN103800370B (zh) | 用于治疗胰功能异常的方法 | |
CN105296418B (zh) | 一种长期体外培养和扩增肝细胞的方法及其应用 | |
CN104263697B (zh) | 一种诱导培养基及诱导人脂肪间充质干细胞生成胰岛素分泌细胞的方法 | |
CN103930542A (zh) | 棕色脂肪细胞组合物及方法 | |
CN110577931B (zh) | 间断缺氧处理干细胞来源外泌体及在心肌组织中的应用 | |
EP4123014A1 (en) | Cardiac organoid, manufacturing method therefor, and method for evaluating drug toxicity by using same | |
CN108330099A (zh) | 个性化肝细胞的培养和扩增方法及其应用 | |
CN109837239A (zh) | 一种人脂肪干细胞原代培养及无血清多向诱导分化方法 | |
CN102899288B (zh) | 一种人胰岛来源的胰腺干细胞系的构建及向胰岛素分泌细胞分化的方法 | |
CN106987555A (zh) | 高效诱导人多能干细胞向心肌细胞分化的小分子化合物组合物 | |
CN110511901A (zh) | 生物人工近端小管系统及使用方法 | |
Sun et al. | Isolation of ready-made rat microvessels and its applications in effective in vivo vascularization and in angiogenic studies in vitro | |
CN108486039A (zh) | 小分子诱导人脂肪干细胞分化为睾丸间质细胞的方法 | |
CN108570446A (zh) | 一种尿液来源细胞的培养方法 | |
Li et al. | An improved two-step method for extraction and purification of primary cardiomyocytes from neonatal mice | |
CN114246883A (zh) | 一种药物组合物及其治疗剂和应用 | |
CN112481216A (zh) | 一种人诱导多能干细胞及其培养方法和用途 | |
CN104755610B (zh) | 脂肪组织细胞 | |
CN103881962A (zh) | 建立大鼠胰腺导管上皮样干细胞系的方法 | |
CN101368170A (zh) | 一种肝细胞和枯否细胞的体外共同培养技术 | |
KR102302931B1 (ko) | 인체 갑상선조직에서 단일세포 분리기법 | |
Apte | Isolation of quiescent pancreatic stellate cells from rat and human pancreas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220107 Address after: 518057 16th floor, Beike building, No. 59, Gaoxin South ninth Road, Yuehai street, Nanshan District, Shenzhen, Guangdong Patentee after: SHENZHEN BEIKE BIO-TECHNOLOGY Co.,Ltd. Address before: 430072 Hubei Province, Wuhan city Wuchang District Luojia Hill Patentee before: WUHAN University |
|
TR01 | Transfer of patent right | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20190514 Assignee: Harbin Beike Health Technology Co.,Ltd. Assignor: SHENZHEN BEIKE BIO-TECHNOLOGY Co.,Ltd. Contract record no.: X2023440020002 Denomination of invention: A kind of pancreatic precursor cells and islets derived from human pluripotent stem cells b Cell method Granted publication date: 20210402 License type: Common License Record date: 20230116 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230802 Address after: 518063 North Science Building 1502, No. 59 Gaoxin South 9th Road, Gaoxin Community, Yuehai Street, Nanshan District, Shenzhen, Guangdong Province Patentee after: Shenzhen Beikeyuan Cell Technology Co.,Ltd. Address before: 518057 16th floor, Beike building, No. 59, Gaoxin South ninth Road, Yuehai street, Nanshan District, Shenzhen, Guangdong Patentee before: SHENZHEN BEIKE BIO-TECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right |